sibutramine has been researched along with Heart Diseases in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alyu, F | 1 |
| Olgar, Y | 1 |
| Degirmenci, S | 1 |
| Turan, B | 1 |
| Ozturk, Y | 1 |
1 other study available for sibutramine and Heart Diseases
| Article | Year |
|---|---|
Interrelated In Vitro Mechanisms of Sibutramine-Induced Cardiotoxicity.
Topics: Action Potentials; Animals; Anti-Obesity Agents; Calcium; Cardiotoxicity; Cyclobutanes; Heart Diseas | 2021 |